Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Titel:
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Auteur:
Itzykson, R. Thépot, S. Beyne-Rauzy, O. Ame, S. Isnard, F. Dreyfus, F. Salanoubat, C. Taksin, A.L. Chelgoum, Y. Berthon, C. Malfuson, J.V. Legros, L. Vey, N. Turlure, P. Gardin, C. Boehrer, S. Ades, L. Fenaux, P.